Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Movement disorders
Which essential tremor phenotypes benefit most from wearable peripheral nerve stimulator devices?
a.k.a. transcutaneous afferent patterned stimulation (TAPS), e.g. Cala kIQ
Related Questions
When do you attribute tremors to lamotrigine?
What is your preferred first-line agent to treat anxiety in patients with Parkinson's disease?
How do you approach a patient with both a resting and action tremor, suggestive of PD and essential tremor together?
What is your approach to the evaluation of minipolymyoclonus?
What do you do for a patient with Parkinson's Disease and orthostatic hypotension who has failed midodrine, fludrocortisone, droxidopa, pyridostigmine, and atomoxetine?
Which imaging features do you use when considering Normal Pressure Hydrocephalus to decide whether to proceed with large-volume LP or lumbar drain trial?
How do you decide between the different oral longer acting levodopa medications?
When do you evaluate patients with Parkinson's disease and cognitive decline for concurrent Alzheimer's disease?
What considerations should you discuss with patients prior to genetic testing for suspected Huntington disease?
What is your approach to Tardive Dyskinesia when VMAT2 inhibitors are ineffective or unaffordable?